ARTICLE | Clinical News
ProSavin regulatory update
November 8, 2010 8:00 AM UTC
The COMP issued a negative opinion to grant Orphan Drug designation for Oxford Biomedica's ProSavin to treat off-periods in adult patients with advanced Parkinson's disease who are not responding adeq...